Global Topical Corticosteroids Market, Size Trends & Growth Opportunity, By Molecule Name (Fludroxycortide, Triamcinolone Acetonide, Fluocinolone Acetonide, Antiseptics, Betamethasone, Clobetasone Propionate, Clobetasone Butyrate, Halobetasone, Mometasone, Others), By Application (Acne, Dermatitis, Psoriasis, Skin Infection, Hyperpigmentation, Melasma, Others), By Medication Type (Ointments, Creams, Liquid & Solutions, Lotions, Gel, Oils, Pastes, Sprays, Others), By End User (Hospital, Dermatology, Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacies, Pharmacy Stores, Online Pharmacies, Others) By Region & Forecast till 2027.
Global Topical Corticosteroids Market
Global Topical Corticosteroids Market was valued at USD 4.85 billion in 2021, would rocket up to USD 6.08 billion by 2027 at a CAGR 5.7% from 2022-2027.
Corticosteroids are the steroid hormones that are produced either by the body or synthetically. These hormones are produced by adrenal cortex. Topical corticosteroids are mostly used to treat a wide range of inflammatory diseases as these are hydrocortisone-derivative compounds with separate anti-inflammatory potency. When the body or adrenal cortex fails to produce the required corticosteroids, the patients are given synthetic corticosteroids.
Market Drivers
Rising figure of acute and chronic inflammatory disease & disorder such as rash, dermatitis, itching, eczema, etc., globally due to various factors is one of the major factors boosting the growth of market. Increasing expenditure for research and development expertise chiefly in the developed and developing countries concerning to the medical instruments and devices will further drive the growth of Global Topical Corticosteroids Market. Increasing focus towards enhancing the condition of healthcare facilities and upgrading the overall healthcare infrastructure are the other important components to drive the growth of market.
Market Restraints
In contrast, high price associated with the research and development expertise, limited infrastructure facilities, rough distribution of medical services and death of awareness in backward countries are restrains the growth of market. Additionally, absence of favourable reimbursement framework and technology penetration in the evolving countries, decrease in the healthcare expenses in the advancing economies, rise in patent expiry, pricing pressure by the government, side effects of topical corticosteroids and absence of suitable infrastructure in low- and middle-income territory are predicted to hamper the market in the forecast period of 2022-2029.
Market Segmentation
The Global Topical Corticosteroids Market is segmented into Molecule Name, Application, Medication, End User, Distribution Channel. By Molecule Name such as Fludroxycortide, Triamcinolone Acetonide, Fluocinolone Acetonide, Antiseptics, Betamethasone, Clobetasone Propionate, Clobetasone Butyrate, Halobetasone, Mometasone, Others. By Application such as Acne, Dermatitis, Psoriasis, Skin Infection, Hyperpigmentation, Melasma, Others. By Medication such as Ointments, Creams, Liquid & Solutions, Lotions, Gel, Oils, Pastes, Sprays, Others), By End User (Hospital, Dermatology, Clinics, Homecare, Others. By Distribution Channel such as Hospital Pharmacies, Pharmacy Stores, Online Pharmacies, Others.
Regional Analysis
The Global Topical Corticosteroids Market is segmented into five regions North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America influences the topical corticosteroids market as of the strong base of healthcare facilities, extensive usage of medication, rise in the cost of health care, fast growth in the incidences of skin diseases, high demand for new topical products for its treatment and increasing number research activities in this region.
Asia pacific is anticipated to significant growth during the forecast period 2022-2027 owing to rise in government initiative to assist awareness, increase in medical tourism, rising research activities in this region, availability of huge untapped markets, great population pool, existence of large number of dermatology clinics, and the increasing demand quality healthcare in this region.
Key Players
Various Key Players are listed in this report such as GlaxoSmithKline plc (UK), Almirall, S.A (Spain), Merck & Co., Inc. (Germany), Bausch Health (Canada), Sandoz International GmbH (Germany), Pfizer Inc. (US), AstraZeneca (UK), Sanofi (France), Bayer AG (Germany), McKesson Corporation (US).
Market Taxonomy
By Molecule Name
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook